PubMed:27003763 / 527-650 JSONTXT

{"project":"sentences","denotations":[{"id":"TextSentencer_T10","span":{"begin":0,"end":123},"obj":"Sentence"},{"id":"T10","span":{"begin":0,"end":123},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The placebo group had a higher number of cases of preeclampsia (11/47) compared with the L-arginine group (3/49, P = 0.01)."}

{"project":"Preeclampsia","denotations":[{"id":"PD-Preeclampsia-B_T4","span":{"begin":50,"end":62},"obj":"ORPHA:275555"}],"namespaces":[{"prefix":"ORPHA","uri":"www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN\u0026Expert="}],"text":"The placebo group had a higher number of cases of preeclampsia (11/47) compared with the L-arginine group (3/49, P = 0.01)."}

{"project":"Preeclampsia-compare","denotations":[{"id":"PD-Preeclampsia-B_T4","span":{"begin":50,"end":62},"obj":"ORPHA:275555"}],"namespaces":[{"prefix":"ORPHA","uri":"www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN\u0026Expert="}],"text":"The placebo group had a higher number of cases of preeclampsia (11/47) compared with the L-arginine group (3/49, P = 0.01)."}

{"project":"yangbin123xm_800_3","denotations":[{"id":"T14","span":{"begin":4,"end":11},"obj":"CI"},{"id":"T4","span":{"begin":89,"end":99},"obj":"CI"}],"text":"The placebo group had a higher number of cases of preeclampsia (11/47) compared with the L-arginine group (3/49, P = 0.01)."}

{"project":"chenxin_473849_800_3","denotations":[{"id":"T4","span":{"begin":89,"end":99},"obj":"CI"},{"id":"T8","span":{"begin":4,"end":11},"obj":"CI"}],"text":"The placebo group had a higher number of cases of preeclampsia (11/47) compared with the L-arginine group (3/49, P = 0.01)."}